TMCnet7h
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...
AnaptysBio, Vanda announce exclusive global license agreement for Vanda
Vanda Pharmaceuticals (VNDA) and AnaptysBio (ANAB) announced an exclusive, global license agreement for the development and commercialization ...
Vanda Pharmaceuticals and AnaptysBio to develop and market imsidolimab
Vanda Pharmaceuticals (VNDA) and AnaptysBio (ANAB) announced an exclusive, global license agreement for the development and commercialization ...
Columbia Daily Tribune10h
Pedestrian projects, other public safety majority of Columbia council's agenda
Proposed projects could improve sidewalks in the Vandiver/Oakland Gravel area and renovations to Fire Station 10's proposed ...
Audit: State continued to use confidentiality agreements after informal NDA ban
A recent audit of Massachusetts state agencies found that they entered into at least 159 settlements between 2010 and 2022 ...